(Q37900922)

English

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

scientific article published on December 1987

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms (English)

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

gram-negative bacteria

0 references

0 references

author name string

Retsema J

1

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Girard A

2

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Schelkly W

3

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Manousos M

4

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Anderson M

5

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Bright G

6

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Borovoy R

7

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Brennan L

8

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Mason R

9

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

language of work or name

0 references

publication date

1 December 1987

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

31

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

1939-1947

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

6 September 2017

Antimicrobial chemotherapy of chlamydial infection: where next?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

6 September 2017

In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

6 September 2017

In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

6 September 2017

In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

6 September 2017

In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

6 September 2017

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

6 September 2017

Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

14 September 2017

Antibiotics as probes of ribosome structure: binding of chloramphenicol and erythromycin to polyribosomes; effect of other antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

28 September 2017

Evaluation of three 4"-deoxy-4"-sulfonamido-oleandomycin derivatives with erythromycin-like antibacterial potency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

23 June 2018

Binding of erythromycin to Escherichia coli ribosomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

23 June 2018

Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175832

23 June 2018

In-vitro activity of erythromycin, roxithromycin and CP 62993 against common paediatric pathogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2449865

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.31.12.1939

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37900922&oldid=1756754329"